American Portfolios Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

American Portfolios Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50	Closed	-$2.17K	–	3335
2020 Q4	$2.17K	Sell	50 -100	-67%	-$4.93K	﹤0.01%	2683
2020 Q3	$8.27K	Buy	150 +125	+500%	+$7.94K	﹤0.01%	2063
2020 Q2	$1.58K	Hold	25	–	–	﹤0.01%	2605
2020 Q1	$1.28K	Sell	25 -75	-75%	-$5.02K	﹤0.01%	2510
2019 Q4	$7.95K	Sell	100 -140	-58%	-$8.3K	﹤0.01%	2092
2019 Q3	$11.6K	Sell	240 -15	-6%	-$782	﹤0.01%	1876
2019 Q2	$13.4K	Buy	255 +230	+920%	+$13.2K	﹤0.01%	1812
2019 Q1	$1.32K	Sell	25 -25	-50%	-$1.23K	﹤0.01%	2444
2018 Q4	$2.05K	Buy	+50	New	+$1.87K	﹤0.01%	2133

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Portfolios Advisors's GBT Position: Q1 2021 in Review

American Portfolios Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 50 shares — an estimated $2.17K sold.

American Portfolios Advisors first reported a position in GBT in Q4 2018 and held it in 9 quarters. The position peaked at $13.4K in Q2 2019. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

American Portfolios Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
American Portfolios Advisors sold 50 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $2.17K.
American Portfolios Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 9 quarters.
American Portfolios Advisors's Global Blood Therapeutics, Inc. position peaked at $13.4K in Q2 2019.
214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.